Jonathan Goldman, M.D.

Jonathan Goldman, M.D.

DirectoratAvalo Therapeutics· In proxies 2023–2025

Jonathan Goldman, M.D. sits on 1 public board.

Boards1

  • Avalo TherapeuticsDirector · -1 yr on the boardIndependentAudit—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. Avalo TherapeuticsPublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role -99%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?